Big pharma’s devastating retreat from the UK September 16, 2025 Merck and AstraZeneca’s withdrawal from UK investment is a warning signal to Rachel Reeves – but is she listening? Asks Oliver Dean Both AstraZeneca and Merck’s decision to abandon their respective UK expansions is more than a corporate setback. It is a catastrophic loss of jobs, investment and future innovation and the public are now [...]
A new LISA life: why the lifetime ISA needs reform July 18, 2025 While the Treasury Committee has criticised the Lifetime ISA (LISA) as poor value for money, helping young people get on the housing ladder remains a worthwhile goal, says Oliver Dean The Treasury Committee has raised valid concerns about the Lifetime ISA’s (LISA) value for money, concluding that in its current form the scheme is not [...]
Why are so many young men turning to Reform February 10, 2025 Young men are flocking to Reform because Nigel Farage is telling them what they want to hear: That they have a voice and it matters, says Oliver Dean British politics appears to have been tipped on its head. Young men who were once considered a sure thing for Labour are now flocking to Reform UK. [...]
